ImmuPharma PLC (LON:IMM) has been personally invited by the president of Mauritius to run some of its clinical trials for Lupuzor, its treatment for Lupus, in the …
source
Have something to say? Leave a comment:
Sign in
Welcome! Log into your account
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.